AJANTA PHARMA LIMITED (AJANTPHARM)

NSE: ₹2,947.70
BSE: ₹2,947.65
Stock Performance
Corporate Announcements
Announcement under Regulation 30 (LODR)-Newspaper Publication

Pls find enclosed newspaper publication of AGM Notice

2026-06-19 12:07:31
Business Responsibility and Sustainability Reporting (BRSR)

Pls find enclosed BRSR for FY 2026.

2026-06-18 10:58:13
Reg. 34 (1) Annual Report.

Pls find enclosed herewith Annual Report for FY 2025-2026.

2026-06-18 10:49:36
Announcement under Regulation 30 (LODR)-Newspaper Publication

Pls find enclosed notice published in newspapers intimating that the 47th AGM of the Company will be held on 16th July 2026.

2026-06-17 12:10:31
Shareholders Meeting- 47Th Annual General Meeting On 16/07/2026

Pls find enclosed herewith AGM Intimation

2026-06-15 09:11:03
Participation In Investor Conference

Pls find enclosed intimation w.r.t participation in investor conference

2026-06-12 16:15:55

Quarterly Financials

Consolidated Standalone
Particulars Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 1,021.04 1,028.44 1,105.15 1,054.08 1,144.92 1,186.64 1,146.13 1,170.41 1,302.65 1,353.73 1,374.84 1,421.64
YOY Revenue Growth % 7.37% 9.63% 13.73% 19.53% 12.13% 15.38% 3.71% 11.04% 13.78% 14.08% 19.95% 21.47%
Other Income 31.75 21.33 13.59 35.50 26.47 19.48 30.44 18.11 26.33 59.34 24.97 61.43
Total Income 1,052.79 1,049.77 1,118.74 1,089.58 1,171.39 1,206.12 1,176.57 1,188.52 1,328.98 1,413.07 1,399.81 1,483.07
Total Expenses + 783.75 773.83 827.83 811.54 849.27 915.88 869.18 919.11 997.85 1,072.26 1,041.21 1,135.96
Cost of Materials Consumed 217.81 223.54 239.05 259.03 238.41 207.09 210.14 190.96 207.08 217.60 235.07 256.76
Employee Benefit Expense 213.21 222.27 231.35 233.51 283.78 260.96 265.17 279.78 302.90 317.01 330.52 340.72
Other Expenses 284.61 259.39 265.56 277.87 262.94 352.83 302.32 310.06 372.52 392.08 375.82 442.70
Operating Profit 237.29 254.61 277.32 242.54 295.65 270.76 276.95 251.30 304.80 281.47 333.63 285.68
OPM % 23.2% 24.8% 25.1% 23% 25.8% 22.8% 24.2% 21.5% 23.4% 20.8% 24.3% 20.1%
Profit Before Tax + 269.04 275.94 290.91 278.04 322.12 290.24 307.39 269.41 331.13 340.81 358.60 347.11
Tax Expense 60.92 80.64 80.88 75.32 76.35 73.76 74.51 44.15 75.79 80.62 84.83 80.41
Tax % 22.6% 29.2% 27.8% 27.1% 23.7% 25.4% 24.2% 16.4% 22.9% 23.7% 23.7% 23.2%
Profit After Tax 208.12 195.30 210.03 202.72 245.77 216.48 232.88 225.26 255.34 260.19 273.77 266.70
EPS (Basic) 16.53 15.51 16.68 16.10 19.54 17.27 18.60 18.00 20.44 20.83 21.91 21.35

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
Revenue from Operations 5,452.86 4,648.10 4,208.71 3,742.64 3,340.99 2,889.69 2,587.87
YOY Revenue Growth % 17.31% 10.44% 12.45% 12.02% 15.62% 11.66% -
Other Income 172.07 94.50 84.60 98.64 115.68 25.98 92.19
Total Income 5,624.93 4,742.60 4,293.31 3,841.28 3,456.67 2,915.67 2,680.06
Total Expenses + 4,247.28 3,553.44 3,179.38 3,096.03 2,547.19 2,015.49 1,809.16
Cost of Materials Consumed 916.51 846.60 939.43 878.36 779.34 706.41 560.33
Employee Benefit Expense 1,291.15 1,089.69 900.34 785.14 645.78 548.25 485.59
Other Expenses 1,583.12 1,228.15 1,069.86 1,123.85 933.64 697.83 763.24
Operating Profit 1,205.58 1,094.66 1,029.33 646.61 793.80 874.20 778.71
OPM % 22.1% 23.6% 24.5% 17.3% 23.8% 30.3% 30.1%
Profit Before Exceptional 1,377.65 1,189.16 1,113.93 745.25 909.48 900.18 667.89
Exceptional Items 0.00 0.00 0.00 0.00 0.00 0.00 -3.92
Profit Before Tax + 1,377.65 1,189.16 1,113.93 745.25 909.48 900.18 663.97
Tax Expense 321.65 268.77 297.76 157.27 196.80 246.31 196.27
Tax % 23.3% 22.6% 26.7% 21.1% 21.6% 27.4% 29.6%
Profit After Tax 1,056.00 920.39 816.17 587.98 712.68 653.87 467.70
EPS (Basic) 84.53 73.56 64.82 45.89 82.45 75.09 53.60

Balance Sheet

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
ASSETS
Non-Current Assets + 2,419.41 2,171.92 1,907.47 1,845.02 1,791.12 1,751.13 0.00
Property, Plant & Equipment 1,726.35 1,624.87 1,384.13 1,407.83 1,424.31 1,429.20 0.00
Capital Work in Progress 258.05 176.27 256.45 209.47 152.86 108.19 0.00
Non-Current Investments 28.50 25.24 18.58 25.10 25.10 0.00 0.00
Goodwill 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Intangible Assets 140.60 137.15 95.06 88.61 79.27 0.00 0.00
Current Assets + 3,735.43 2,829.70 2,722.07 2,825.18 2,264.46 2,027.59 0.00
Inventories 938.54 903.85 828.36 815.63 791.07 766.47 0.00
Trade Receivables 1,853.88 1,182.74 1,246.84 1,056.90 1,019.81 738.43 0.00
Cash and Cash Equivalents 103.26 175.12 129.49 329.83 206.36 177.51 0.00
Current Investments 559.85 438.71 330.05 510.27 121.86 175.67 0.00
LIABILITIES & EQUITY
Total Equity 4,527.09 3,790.29 3,567.36 3,387.99 3,264.35 2,995.63 0.00
Equity Share Capital 25.07 25.07 25.27 25.27 17.17 17.39 0.00
Other Equity 4,502.02 3,765.22 3,542.09 3,362.72 3,247.18 2,978.24 0.00
Non-Current Liabilities 212.00 228.56 175.27 151.75 143.85 134.46 0.00
Current Liabilities 1,415.75 996.10 895.25 1,139.28 647.38 648.63 0.00
Total Liabilities 1,627.75 1,224.66 1,071.03 1,291.03 791.23 783.09 0.00

Cash Flow Statement

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
Cash from Operating Activities 529.19 1,157.23 785.07 791.78 562.04 576.31 0.00
Cash from Investing Activities -428.92 -376.52 65.39 -559.60 -74.10 -282.38 0.00
Cash from Financing Activities -167.92 -733.41 -1,051.06 -107.87 -460.04 -318.29 0.00
Net Increase/Decrease in Cash -71.86 45.63 -200.34 123.47 28.85 -24.36 0.00